Page 1

Interim report January - March 2021 Gradual recovery and strong order intake Quarter January - March 2021 ▸ Net sales amounted to SEK 100.6 ( 118.4 ) million , a decline of 15.0 percent . After adjustment for currency effects , the decline is 6.2 percent . ► The number of instruments sold amounted to 931 ( 912 ) , an increase of 2.1 percent . ▸ Cash flow from operating activities amounted to SEK 12.6 ( 14.5 ) million . ► Operating profit was SEK 6.8 ( 15.2 ) million , corresponding to an operating margin of 6.8 ( 12.9 ) percent . ► Profit after tax amounted to SEK 0.3 ( 7.4 ) million . ► Basic and diluted earnings per share amounted to SEK 0.02 ( 0.38 ) . Significant events during the quarter No significant events occurred during the quarter . Significant events after the period No significant events have occurred after the end of the period . Jan - Mar Key figures 2021 Jan - Mar 2020 Apr 20 - Mar 21 ( R12 ) Apr 19 - Mar 20 ( R12 ) Sales growth , % -15.0 -0.2 -23.3 12.4 Net sales , SEK million 100.6 118.4 382.7 498.7 Gross margin , % 44.4 46.6 43.6 45.6 Operating profit ( EBIT ) , SEK million 6.8 15.2 -14.3 68.6 Operating margin ( EBIT ) , % 6.8 12.9 -3.7 13.8 Profit after tax , SEK million 0.3 7.4 -55.0 35.1 Net debt , SEK million -3.2 2.8 -3.2 2.8 Return on equity , % 0.1 2.2 -17.5 10.5 Net debt / EBIT ( R12 ) , times 0.2 0.0 0.2 0.0 Diluted earnings per share , SEK 0.02 0.38 -2.83 1.81 Net sales ( R12 ) and EBIT ( R12 ) Net sales 600 500 100 80 60 400 300 40 200 20 100 0 0 -20 Q1 2019 Q2 2019 Q3 2019 Q4 2019 EBIT , SEK million Q1 2020 Q2 2020 Q3 2020 Q4 2020 Q1 2021 - Net sales , SEK million BOULE DIAGNOSTICS INTERIM REPORT JANUARY - MARCH 2021 1 EBIT Boule